U.S. Markets close in 23 mins

ACETO unit to launch generic version of Cleocin Pediatric

ACETO Corporation (ACET) announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, has launched the generic version of the 75mg/*5mL strength of Clindamycin Palmitate Hydrochloride for Oral Solution, USP, an FDA approved generic version of Pfizer's (PFE) Cleocin Pediatric. According to IMS Health data, U.S. market sales for Clindamycin Palmitate Hydrochloride, which is an antibiotic that is used to treat serious infections caused by bacteria, were approximately $59M for the twelve months ended June 30.